Winslow Evans & Crocker’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $224K | Buy |
+1,593
| New | +$224K | 0.04% | 319 |
|
|
2020
Q3 | – | Sell |
-40
| Closed | -$4K | – | 1176 |
|
|
2020
Q2 | $4K | Hold |
40
| – | – | ﹤0.01% | 947 |
|
|
2020
Q1 | $4K | Hold |
40
| – | – | ﹤0.01% | 951 |
|
|
2019
Q4 | $4K | Hold |
40
| – | – | ﹤0.01% | 1042 |
|
|
2019
Q3 | $4K | Sell |
40
-36
| -47% | -$3.6K | ﹤0.01% | 1035 |
|
|
2019
Q2 | $8K | Hold |
76
| – | – | ﹤0.01% | 896 |
|
|
2019
Q1 | $8K | Hold |
76
| – | – | ﹤0.01% | 893 |
|
|
2018
Q4 | $6K | Sell |
76
-124
| -62% | -$9.79K | ﹤0.01% | 902 |
|
|
2018
Q3 | $20K | Buy |
200
+34
| +20% | +$3.4K | 0.01% | 669 |
|
|
2018
Q2 | $16K | Buy |
166
+50
| +43% | +$4.82K | 0.01% | 728 |
|
|
2018
Q1 | $10.1K | Buy |
+116
| New | +$10.1K | ﹤0.01% | 788 |
|